About this trial
This study is based on the previously constructed digital rehabilitation management platform, scientifically evaluating the clinical efficacy of guided technology in improving IPF exercise endurance, and forming high-quality clinical evidence.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients who meet the diagnostic criteria for IPF;
Those who can tolerate guided - technique training;
Aged between 40 and 85 years old;
Those who can independently or with the assistance of family members use devices such as smartphones and computers during home - based training;
Disqualifiers
Patients in the acute exacerbation phase of IPF.
Patients with comorbidities such as chronic obstructive pulmonary disease, lung cancer, active pulmonary tuberculosis, bronchiectasis, pulmonary embolism, and other pulmonary diseases.
Patients with severe cardiovascular and cerebrovascular diseases (malignant arrhythmia, unstable angina pectoris, acute myocardial infarction, cardiac function at grade 3 or above, stroke, cerebral hemorrhage, etc.).
Patients with severe liver diseases (such as bleeding caused by liver cirrhosis, portal hypertension, and esophagogastric varices) and severe kidney diseases (dialysis, kidney transplantation, etc.).
Trial design
Parallel
Treatments tested in this trial
Daoyin Technique
BehavioralOn the basis of treatment guided by "Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline ", the experimental group was given Daoyin Technique for treatment. For patients who are able to complete the respiratory guidance technique. For patients who are unable to complete the respiratory guidance technique but have stable vital signs (referring to the "Expert Consensus on Respiratory Critical Care Rehabilitation Treatment Techniques in China"), the supine guidance technique is selected. It is carried out 5 days a week, 2 times a day, and each training session lasts for 30 minutes.
Routine Comprehensive Training
BehavioralOn the basis of treatment guided by I"Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline",the experimental group was given Routine Comprehensive Training. According to the patient's condition, select aerobic training (such as walking) or upper - limb and lower - limb resistance training (such as lifting, chest - expanding, foot - pedaling movements, etc.) combined with respiratory training (such as pursed - lip breathing, abdominal breathing, etc.). The heart rate should reach the target heart rate range and last for more than 10 minutes. This training is carried out 5 days a week, 2 times a day.
Treatment groups
Trial outcomes
Primary outcomes
6 Six Minute Walk Distance(6MWD)
6MWD will be applied to evaluate the exercise capacity. The higher values indicate the better exercise capacity.
the 30 - second sit - to - stand test(30s STS)
30s STS will be used to assess pulmonary function.
Secondary outcomes
The time of the first acute exacerbation
The time of the patients' first acute exacerbation will be recorded.
Frequency of acute exacerbation
Frequency of acute exacerbation will be recorded.
Frequency of acute exacerbations resulting in hospitalization
Frequency of acute exacerbation resulting in hospitalization will be recorded.
Frequency of acute exacerbations resulting in ICU admission
Frequency of acute exacerbation resulting in ICU admission will be recorded.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Affiliated Hospital of Liaoning University of Traditional Chinese Medicine
Lead sponsor
The First Affiliated Hospital of Henan University of Traditional Chinese Medicine
Collaborator
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Collaborator